Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 02 Apr 2025

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

in Molecular and Cellular Oncology

Sanjib Saha
Ulf-Göran Gerdtham
Gottfrid Sjödahl
Christel Häggström
James W. F. Catto
John D. Kelly
Anders Ullén
Lars Holmberg
Fredrik Liedberg

Frontiers in Oncology

doi 10.3389/fonc.2025.1556881

Review

Published on 02 Apr 2025

Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers

in Molecular and Cellular Oncology

Reem A. Assal
Hannah H. Rashwan
Zeina I. Zakaria
Jana H. Sweillam
Yasmine M. Fouda
Abdelhamid M. Abdelhamid
Rana A. Youness

Frontiers in Oncology

doi 10.3389/fonc.2025.1519103

239 views

Review

Published on 01 Apr 2025

LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies

in Molecular and Cellular Oncology

WeiChi Liu
WeiFa Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1552773

133 views

Systematic Review

Published on 31 Mar 2025

The rising influence of lipid metabolism in lung cancer: a global research perspective

in Molecular and Cellular Oncology

Chaoqun Wang
Ming Lei
Wei Wang
Yuanyuan Jiang
Jiefeng Zhang
Yi Zhang
Bin Zhao
Wenyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1562621

135 views

Review

Published on 31 Mar 2025

Liquid-liquid phase separation in cell physiology and cancer biology: recent advances and therapeutic implications

in Molecular and Cellular Oncology

Ziyuan Huang
Zimeng Liu
Lieqian Chen
Yanlin Liu
Gaofei Yan
Yizheng Ni
Qiuxia Yan
Wenqian He
Junhong Liu
Shufang Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1540427

198 views

Mini Review

Accepted on 27 Mar 2025

A review shows that ATG10 has been identified as a potential prognostic marker and therapeutic target for cancer patients based on real-world studies

in Molecular and Cellular Oncology

Ke Shi
Di Ke
Feng Li
Rong-Shu Shi
Tao Liu
Dan Li
Qun-Xian Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1573378

Editorial

Accepted on 27 Mar 2025

Editorial: Deciphering the Role of Signature Genes in Cancer Prognosis and Therapy Resistance

in Molecular and Cellular Oncology

DALILA LUCIOLA ZANETTE
Manoj K. Pandey
Jawed A Siddiqui

Frontiers in Oncology

doi 10.3389/fonc.2025.1591256

Review

Published on 27 Mar 2025

The NIMA-related kinase family and cancer

in Molecular and Cellular Oncology

Haotian Li
Junhan Li
Yue Zhang
Ran Cao
Congcong Guo
Mingwen Jiao

Frontiers in Oncology

doi 10.3389/fonc.2025.1556917

159 views

Original Research

Accepted on 26 Mar 2025

Examination of the Functions and Mechanism of KCP in Mediating Paclitaxel Resistance in Cervical Squamous Carcinoma Cells

in Molecular and Cellular Oncology

Yue He
Jian-Qing Xu
Jing-Jing Zhang
Zhen-You Liu
Chen Ji
Yang Liu
Yun-Fan Wang
Ming Wang
Yumei Wu
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1550032

Original Research

Accepted on 26 Mar 2025

Single-Cell Transcriptomics and Functional Validation Revealed PLEKHA5-L as a Promoter of Growth and Migration in Brain Metastatic Melanoma Cells

in Molecular and Cellular Oncology

XiaoGen Tang
Boya Huang
Tingting Lei
Guangjie Wu
Yizhen Tian
Jan jian Xiang
Dongwei Fu
Hongyi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1560954

Original Research

Accepted on 25 Mar 2025

Overexpression of MMP14 is associated with Poor Prognosis and Immune Cell Infiltration in Colon Cancer

in Molecular and Cellular Oncology

Na Li
Nan Zhang
Guanghui Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564375

Original Research

Published on 24 Mar 2025

RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70

in Molecular and Cellular Oncology

Maxim Shevtsov
Natalia Yudintceva
Danila Bobkov
Ruslana Likhomanova
Anastasiya Nechaeva
Elena Mikhailova
Elena Oganesyan
Viacheslav Fedorov
Andrey Kurkin
Anastasiya Lukacheva

Frontiers in Oncology

doi 10.3389/fonc.2025.1543657

568 views

Review

Published on 24 Mar 2025

The interrelated roles of RAB family proteins in the advancement of neoplastic growth

in Molecular and Cellular Oncology

Yuxin Ji
Ruonan Li
Guohui Tang
Wenrui Wang
Changjie Chen
Qingling Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1513360

203 views

Correction

Accepted on 21 Mar 2025

Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

in Molecular and Cellular Oncology

Tomasz Sirek
Katarzyna Król-Jatręga
Przemysław Borawski
Nikola Zmarzły
Dariusz Boron
Piotr Ossowski
Olga Nowotny-Czupryna
Kacper Boroń
Dominika Janiszewska-Bil
Elżbieta Mitka-Krysiak

Frontiers in Oncology

doi 10.3389/fonc.2025.1558771

Review

Published on 21 Mar 2025

Research progress of ferroptosis pathway and its related molecular ubiquitination modification in liver cancer

in Molecular and Cellular Oncology

Silin Yao
Yi Quan

Frontiers in Oncology

doi 10.3389/fonc.2025.1502673

238 views

Review

Published on 21 Mar 2025

Repurposing alternative splicing events as potential targets for the design of diagnostic and therapeutic tools in PCa

in Molecular and Cellular Oncology

Nancy Martínez-Montiel
José de Jesús Vite-Arciniega
Nora Hilda Rosas-Murrieta
Rebeca D. Martínez-Contreras

Frontiers in Oncology

doi 10.3389/fonc.2025.1520985

176 views